Ryan Specialty (NYSE:RYAN) Price Target Lowered to $55.00 at Morgan Stanley

Ryan Specialty (NYSE:RYAN) had its price objective trimmed by Morgan Stanley from $61.00 to $55.00 in a report issued on Monday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research firms also recently weighed in on RYAN. Jefferies Financial Group started coverage on Ryan Specialty in a report on Monday, December 1st. They set a “hold” rating and a $64.00 target price for the company. TD Cowen reiterated a “buy” rating on shares of Ryan Specialty in a research note on Wednesday, November 26th. Mizuho set a $53.00 price objective on shares of Ryan Specialty in a report on Friday, February 13th. Barclays lowered their target price on shares of Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Finally, The Goldman Sachs Group set a $61.00 price target on Ryan Specialty in a research note on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Ryan Specialty has an average rating of “Moderate Buy” and an average target price of $59.00.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $38.90 on Monday. The company has a market capitalization of $10.28 billion, a price-to-earnings ratio of 92.62, a PEG ratio of 1.07 and a beta of 0.62. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a 12 month low of $37.29 and a 12 month high of $77.16. The stock’s 50 day moving average is $48.54 and its 200-day moving average is $53.15.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.05). The firm had revenue of $751.21 million for the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The business’s revenue for the quarter was up 13.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.45 earnings per share. Equities research analysts expect that Ryan Specialty will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be paid a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.3%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date of this dividend is Tuesday, February 24th. Ryan Specialty’s payout ratio is 114.29%.

Insiders Place Their Bets

In other Ryan Specialty news, CEO Timothy William Turner sold 129,570 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer owned 12,553 shares of the company’s stock, valued at approximately $672,966.33. This trade represents a 91.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 52.21% of the stock is owned by insiders.

Institutional Trading of Ryan Specialty

Several large investors have recently bought and sold shares of RYAN. Vulcan Value Partners LLC lifted its holdings in shares of Ryan Specialty by 631.7% in the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock worth $238,536,000 after acquiring an additional 3,989,502 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Ryan Specialty by 79.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock valued at $389,910,000 after purchasing an additional 3,353,926 shares during the last quarter. Independent Franchise Partners LLP acquired a new stake in Ryan Specialty in the third quarter valued at approximately $95,798,000. Adage Capital Partners GP L.L.C. boosted its position in Ryan Specialty by 1,510.0% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 1,610,000 shares of the company’s stock valued at $83,124,000 after buying an additional 1,510,000 shares in the last quarter. Finally, Champlain Investment Partners LLC grew its stake in shares of Ryan Specialty by 76.9% during the third quarter. Champlain Investment Partners LLC now owns 3,066,011 shares of the company’s stock worth $172,800,000 after buying an additional 1,332,773 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.